Nicole Murphy
Vermogen: 3 M $ op 31-12-2025
Profiel
Nicole Murphy currently works at Biogen, Inc., as Head-Pharmaceutical Operations & Technology from 2022.
Ms. Murphy also formerly worked at Amgen, Inc., as Executive Director & Head-Supply Chain, Bioverativ, Inc., as Head-Technical Operations & Vice President, and Biogen, Inc., as General Manager & Head-Cambridge Site Operations from 2015 to 2016.
Ms. Murphy received her graduate degree and Masters Business Admin degree from Rensselaer Polytechnic Institute and undergraduate degree from the University of Massachusetts.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOGEN INC. 0,01% | 21-04-2025 | 14.223 ( 0,01% ) | 3 M $ | 31-12-2025 |
Actieve functies van Nicole Murphy
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOGEN INC. | Operationeel Directeur | 01-02-2022 |
Eerdere bekende functies van Nicole Murphy
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-12-2016 |
| AMGEN INC. | Directeur/Bestuurslid | - |
| BIOVERATIV INC | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Nicole Murphy
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. Discovers, develops, manufactures and delivers human therapeutics | |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
Bioverativ, Inc. Develops therapies for people living with hemophilia |
















